Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00201656 · ClinicalTrials.gov registry record · Phase 4
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
A Phase 4 study, sponsored by Obstetrix Medical Group.
- Terminated
- Registry status
- Phase 4
- Development phase
- 58
- Enrollment target
NCT00201656 is a Phase 4 study that was terminated before completion, run by Obstetrix Medical Group. The registered enrollment target is 58 participants.
The verdict
NCT00201656, a Phase 4 study, was terminated before completion, sponsored by Obstetrix Medical Group.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 58 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether retention of cervical cerclage after PPROM improves latency (without a significant increase in chorioamnionitis) and lessens neonatal morbidity.
Interventions
- PROCEDURE Retention of Cerclage
- PROCEDURE Removal of Cerclage
- PROCEDURE Removal vs. Retention of Cervical Cerclage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2004-11 |
| Est. Completion | 2014-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00201656
The ClinicalTrials.gov registry entry for NCT00201656 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Obstetrix Medical Group, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Retention of Cerclage is the first listed.
NCT00201656 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00201656 about?
NCT00201656 is a clinical study titled "Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)". The purpose of this study is to determine whether retention of cervical cerclage after PPROM improves latency (without a significant increase in chorioamnionitis) and lessens neonatal morbidity.
What is the current status of trial NCT00201656?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 58 participants. The study started on 2004-11. Estimated completion is 2014-04.
What interventions are being tested in trial NCT00201656?
The interventions under investigation include: Retention of Cerclage (PROCEDURE), Removal of Cerclage (PROCEDURE), Removal vs. Retention of Cervical Cerclage (PROCEDURE).
Who is sponsoring clinical trial NCT00201656?
This trial is sponsored by Obstetrix Medical Group, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.